ETHOSUXIMIDE
Substance profile for UNII 5SEH9X1D1D, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Structure render from PubChem CID 3291Substance Identity#
- UNII
- 5SEH9X1D1D
- Preferred term
- ETHOSUXIMIDE
- Registry number
- 77-67-8
- EC number
- 201-048-7
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C7H11NO2
Structure render from PubChem CID 3291Chemical And Database Identifiers#
- SMILES
- CCC1(C)CC(=O)NC1=O
- RxCUI
- 4135
- PubChem
- 3291
- NCIt
- C47523
- INN ID
- 1077
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| Ethosuximide | ACTIVE INGREDIENT | 5SEH9X1D1D | Ethosuximide Capsules, USP | 1 | |
| Ethosuximide | ACTIVE MOIETY | 5SEH9X1D1D | Ethosuximide Capsules, USP | 1 | |
| ETHOSUXIMIDE | ACTIVE INGREDIENT | 5SEH9X1D1D | Ethosuximide Capsules,USP | 1 | |
| ETHOSUXIMIDE | ACTIVE MOIETY | 5SEH9X1D1D | Ethosuximide Capsules,USP | 1 | |
| ETHOSUXIMIDE | ACTIVE INGREDIENT | 5SEH9X1D1D | ZARONTIN (ETHOSUXIMIDE) CAPSULE [PARKE-DAVIS DIV OF PFIZER INC] | 14 | |
| ETHOSUXIMIDE | ACTIVE MOIETY | 5SEH9X1D1D | ZARONTIN (ETHOSUXIMIDE) CAPSULE [PARKE-DAVIS DIV OF PFIZER INC] | 14 | |
| ETHOSUXIMIDE | ACTIVE INGREDIENT | 5SEH9X1D1D | ZARONTIN (ETHOSUXIMIDE) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC] | 12 | |
| ETHOSUXIMIDE | ACTIVE MOIETY | 5SEH9X1D1D | ZARONTIN (ETHOSUXIMIDE) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC] | 12 | |
| ETHOSUXIMIDE | ACTIVE MOIETY | 5SEH9X1D1D | ETHOSUXIMIDE CAPSULE [PLIVA INC.] | 9 | |
| ETHOSUXIMIDE | ACTIVE INGREDIENT | 5SEH9X1D1D | ETHOSUXIMIDE CAPSULE [PLIVA INC.] | 9 | |
| ETHOSUXIMIDE | ACTIVE INGREDIENT | 5SEH9X1D1D | ETHOSUXIMIDE SOLUTION [TEVA PHARMACEUTICALS USA INC] | 5 | |
| ETHOSUXIMIDE | ACTIVE MOIETY | 5SEH9X1D1D | ETHOSUXIMIDE SOLUTION [TEVA PHARMACEUTICALS USA INC] | 5 | |
| ETHOSUXIMIDE | ACTIVE MOIETY | 5SEH9X1D1D | ETHOSUXIMIDE SOLUTION [PHARMACEUTICAL ASSOCIATES, INC.] | 4 | |
| ETHOSUXIMIDE | ACTIVE INGREDIENT | 5SEH9X1D1D | ETHOSUXIMIDE SOLUTION [PHARMACEUTICAL ASSOCIATES, INC.] | 4 | |
| ETHOSUXIMIDE | ACTIVE MOIETY | 5SEH9X1D1D | ETHOSUXIMIDE CAPSULE [VERSAPHARM INCORPORATED] | 3 | |
| ETHOSUXIMIDE | ACTIVE INGREDIENT | 5SEH9X1D1D | ETHOSUXIMIDE CAPSULE [VERSAPHARM INCORPORATED] | 3 | |
| ETHOSUXIMIDE | ACTIVE MOIETY | 5SEH9X1D1D | ETHOSUXIMIDE SOLUTION [MIKART, INC.] | 3 | |
| ETHOSUXIMIDE | ACTIVE INGREDIENT | 5SEH9X1D1D | ETHOSUXIMIDE SOLUTION [MIKART, INC.] | 3 | |
| ETHOSUXIMIDE | ACTIVE MOIETY | 5SEH9X1D1D | ETHOSUXIMIDE CAPSULE [GREENSTONE LLC] | 2 | |
| ETHOSUXIMIDE | ACTIVE INGREDIENT | 5SEH9X1D1D | ETHOSUXIMIDE CAPSULE [GREENSTONE LLC] | 2 | |
| ETHOSUXIMIDE | ACTIVE INGREDIENT | 5SEH9X1D1D | ETHOSUXIMIDE SOLUTION [GREENSTONE LLC] | 2 | |
| ETHOSUXIMIDE | ACTIVE MOIETY | 5SEH9X1D1D | ETHOSUXIMIDE SOLUTION [GREENSTONE LLC] | 2 | |
| ETHOSUXIMIDE | ACTIVE MOIETY | 5SEH9X1D1D | ETHOSUXIMIDE SOLUTION [VERSAPHARM INCORPORATED] | 2 | |
| ETHOSUXIMIDE | ACTIVE INGREDIENT | 5SEH9X1D1D | ETHOSUXIMIDE SOLUTION [VERSAPHARM INCORPORATED] | 2 | |
| ETHOSUXIMIDE | ACTIVE INGREDIENT | 5SEH9X1D1D | ETHOSUXIMIDE CAPSULE [HERITAGE PHARMACEUTICALS INC.] | 1 | |
| ETHOSUXIMIDE | ACTIVE MOIETY | 5SEH9X1D1D | ETHOSUXIMIDE CAPSULE [HERITAGE PHARMACEUTICALS INC.] | 1 | |